VINBLASTINE SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Vinblastine Sulfate patents expire, and when can generic versions of Vinblastine Sulfate launch?
Vinblastine Sulfate is a drug marketed by Abraxis Pharm, Fresenius Kabi Usa, Hikma, and Hospira. and is included in four NDAs.
The generic ingredient in VINBLASTINE SULFATE is vinblastine sulfate. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vinblastine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vinblastine Sulfate
A generic version of VINBLASTINE SULFATE was approved as vinblastine sulfate by HIKMA on April 9th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VINBLASTINE SULFATE?
- What are the global sales for VINBLASTINE SULFATE?
- What is Average Wholesale Price for VINBLASTINE SULFATE?
Summary for VINBLASTINE SULFATE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 52 |
| Clinical Trials: | 71 |
| Patent Applications: | 4,701 |
| DailyMed Link: | VINBLASTINE SULFATE at DailyMed |
Recent Clinical Trials for VINBLASTINE SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hospital Universitario Dr. Jose E. Gonzalez | Phase 2 |
| University of Washington | Phase 2 |
| AstraZeneca | Phase 2 |
Pharmacology for VINBLASTINE SULFATE
| Drug Class | Vinca Alkaloid |
Medical Subject Heading (MeSH) Categories for VINBLASTINE SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for VINBLASTINE SULFATE
US Patents and Regulatory Information for VINBLASTINE SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | VINBLASTINE SULFATE | vinblastine sulfate | INJECTABLE;INJECTION | 089011-001 | Nov 18, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | VINBLASTINE SULFATE | vinblastine sulfate | INJECTABLE;INJECTION | 089565-001 | Aug 18, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fresenius Kabi Usa | VINBLASTINE SULFATE | vinblastine sulfate | INJECTABLE;INJECTION | 089515-001 | Apr 29, 1987 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | VINBLASTINE SULFATE | vinblastine sulfate | INJECTABLE;INJECTION | 089395-001 | Apr 9, 1987 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
